ストックスクリーナーアプリを入手
1.89
94.44%
-32.08
アフターアワーズ：
1.89
前日終値:
$33.97
開ける：
$1.86
24時間の取引高:
521.95K
Relative Volume:
66.00
時価総額：
$1.49B
収益：
-
当期純損益:
-
株価収益率:
1.9286
EPS:
0.98
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-94.44%
1か月 パフォーマンス:
-94.44%
6か月 パフォーマンス:
-94.44%
1年 パフォーマンス:
-94.44%
1日の値動き範囲:
$1.69
$1.9452
1週間の範囲:
$1.69
$1.9452
52週間の値動き範囲:
$1.69
$1.9452
Meridian Bioscience Inc. Stock (VIVO) Company Profile
名前
Meridian Bioscience Inc.
セクター
電話
513-271-3700
住所
3471 River Hills Drive, Cincinnati, OH
Compare VIVO vs TMO, DHR, IDXX, A, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VIVO
Meridian Bioscience Inc.
|
1.89 | 1.49B | 0 | 0 | 0 | 0.00 |
|
TMO
Thermo Fisher Scientific Inc
|
470.00 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
191.39 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
586.37 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.83 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
290.02 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Meridian Bioscience Inc. Stock (VIVO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-08-11 | 再開されました | Piper Sandler | Overweight |
| 2020-07-27 | 開始されました | H.C. Wainwright | Buy |
| 2020-05-11 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2019-05-01 | アップグレード | Piper Jaffray | Underweight → Neutral |
| 2019-04-03 | ダウングレード | Canaccord Genuity | Hold → Sell |
| 2018-01-26 | 繰り返されました | Canaccord Genuity | Hold |
| 2017-03-28 | 開始されました | CL King | Neutral |
| 2016-03-28 | 繰り返されました | Canaccord Genuity | Hold |
| 2015-09-10 | 繰り返されました | Canaccord Genuity | Hold |
| 2015-07-27 | 繰り返されました | Canaccord Genuity | Hold |
| 2015-05-04 | 繰り返されました | Canaccord Genuity | Hold |
| 2014-11-06 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2012-07-27 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2011-04-25 | アップグレード | Wedbush | Underperform → Neutral |
| 2011-03-24 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2010-11-16 | 開始されました | Canaccord Genuity | Hold |
| 2010-04-07 | 開始されました | Wedbush | Underperform |
| 2009-11-13 | 繰り返されました | Caris & Company | Average |
| 2009-07-07 | 開始されました | Caris & Company | Average |
| 2009-03-06 | 開始されました | William Blair | Mkt Perform |
すべてを表示
Meridian Bioscience Inc. (VIVO) 最新ニュース
ICE Mark Awarded to Meridian Bioscience for Alethia Molecular Assay Portfolio - Medical Product Outsourcing
Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio - Bluefield Daily Telegraph
EU’s stricter test rules: Meridian Alethia assays clear IVDR hurdle - Stock Titan
Meridian Life Science Expands Ambient-Stable NGS Portfolio with the Launch of a Lyophilized Enzymatic DNA Fragmentation Kit - The Joplin Globe
IVD Contract Manufacturing Market Size to Reach USD 43.79 - GlobeNewswire
Cleveland biotech firm adds veteran CEO to lead board during growth phase - Crain's Cleveland Business
Shigella Test Kit Market 2026 Is Booming Worldwide by 2033 - openPR.com
Isothermal Nucleic Acid Amplification Technology Market to Worth Over US$ 17.26 Billion by 2033 | Astute Analytica - GlobeNewswire
NeoGenomics Adds Diagnostics Executive Jack Kenny To Board - Pulse 2.0
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors - BioSpace
Abilene Topic MERIDIAN BIOSCIENCE, INC. | News, Weather, Sports, Breaking News - KTXS
Rapid Medical Diagnostics Market Analysis 2025: Outlook in GCC - openPR.com
Multiplex PCR Kit Market Size to Lead at 10.64% CAGR by 2034 - GlobeNewswire
Yeast Infection Diagnostics Market Share Analysis | CAGR of 6.3% - Market.us
Breath Analyzers Market Opportunities, Key Trends, - openPR.com
United States Malaria Diagnostics Market 2025: Industry - openPR.com
2nd Ex-Magellan Exec Avoids Jail Over Faulty Lead Tests - Law360
Ex-CEO of Magellan Diagnostics avoids prison over lead-test device defect - Reuters
Bioline Launches ISOLATE II, a Precious Find for DNA and RNA Isolation - AOL.com
Shigella Test Kit Market Is Booming Worldwide 2025-2032 | Thermo - openPR.com
Feds, Ex-Magellan CEO Still Split Over Sentencing Factors - Law360
Helicobacter Pylori Non-Invasive Testing Market Size | CAGR 7.2% - Market.us
Growing Greater Cincinnati diagnostics company Meridian Bioscience names new CEO - The Business Journals
Meridian Bioscience, Inc. Announces Chief Financial Officer Changes, Effective October 14, 2025 - MarketScreener
Meridian Bioscience, Inc. Announces Executive Changes - MarketScreener
Meridian Bioscience, Inc. Promotes Andy Kitzmiller to Chief Executive Officer, Effective October 14, 2025 - MarketScreener
Meridian Bioscience Appoints New CEO and Executive Team to Accelerate Global Growth - WV News
Biotech firm to build new manufacturing facility in suburban Cincinnati - WKRC
Meridian Bioscience to create new advanced manufacturing facility in Cincinnati suburb - The Business Journals
Meridian Bioscience Eliminates Cold Chain with the First Liquid Ambient Temperature Stable qPCR Master Mixes - Eastern Progress
Chronic Hepatitis B Virus Testing Market | Global Market Analysis Report2035 - Future Market Insights
Meridian BioscienceFinancial Details - Crunchbase
Revenue of Meridian Bioscience Inc from 2018 to 2022 - Statista
Judge Casts Doubt On Plea Deals In Blood Test Defect Case - Law360
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 - globaldata.com
Rapid Tests Market to Hit USD 3.08 Billion by 2032, Driven by Rising Demand for Quick Diagnostics | SNS Insider - GlobeNewswire
Influenza Diagnostics Market Size to Hit USD 2.45 Billion - GlobeNewswire
Former Magellan Diagnostics CEO pleads guilty over lead-test device defect - Reuters
Influenza Diagnostics Market Revenue to Exceed $2.0 Bn by 2031 Amid Rising Cases and Demand for Rapid Testing – TMR Insights - PharmiWeb.com
Former Magellan exec to plead guilty to concealing lead testing device defect - Reuters
TMU to recognize outstanding honorees at 27th Bishop William A. Hughes Award Dinner April 2 - NKyTribune
Europe Hospital Acquired Infections Diagnostics Market, 2030 - Grand View Research
Chlamydia Market Report 2034: Epidemiology Data, Pipeline - openPR.com
Point of Care (POC) Diagnostics Market to Grow by USD 16.42 Billion (2024-2028) Geriatric Population Boosts Growth, Report on AI-Powered Market EvolutionTechnavio - PR Newswire
Hiv 1 Testing Market Overall Study Report 2024-2032 | BioRad Laboratories ,Meridian Bioscience, Inc. ,Grifols ,BD - openPR.com
Population dynamics of sympatric Phortica spp. and first record of stable presence of Phortica oldenbergi in a Thelazia callipaeda-endemic area of Italy - Parasites & Vectors
Lead testing device company Magellan sentenced for concealing defects - Reuters
In Vitro Diagnostics Contract Manufacturing Market Report, 2030 - Grand View Research
Biosensors Market Size to Exceed USD 58.44 Billion by 2033 - BioSpace
Korean firms acquire US-based Meridian Bioscience for $1.53bn - Private Equity Insights
Judge questions 'unusual' DOJ plan to pay lead-testing device victims - Reuters
Meridian Bioscience Inc. (VIVO) 財務データ
Meridian Bioscience Inc. (VIVO) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.38%
1.16%
大文字化:
|
ボリューム (24 時間):